What do patients with brain metastases from non-small cell lung cancer want from their treatment?

Palliative Medicine

Volumn 23, Issue 7, 2009, Pages 594-600

  Dorman, Saskie ^a   Hayes, J ^b   Pease, N ^c  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b Holme Tower Marie Curie Centre ^*  (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

Brain metastases; Interpretative phenomenological analysis; Lung neoplasms; Patient preference; Qualitative research; Quality of life

Indexed keywords

STEROID;

ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITY CONTROL; QUALITY OF LIFE; SEMI STRUCTURED INTERVIEW; SOCIAL SUPPORT; WHOLE BRAIN RADIOTHERAPY;

ATTITUDE TO DEATH; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DECISION MAKING; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS; QUALITATIVE RESEARCH; QUALITY OF LIFE;

EID: 71049126115     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216309105787     Document Type: Article

References (21)

1. Taimur, S., Edelman, MJ Treatment options for brain metastases in patients with non-small cell lung cancer. Curr Oncol Rep 2003; 5: 342-346.
2. Soffretti, R., Ruda, R., Trevisan, E. Brain metastases: Current management and new developments. Curr Opin Oncol 2008; 20: 676-684.
3. Tsao, MN, Lloyd, N., Wong, R., Chow, E., Rakovitch, E., Laperriere, N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database of Systematic Reviews 2006, Issue 3, Art. No.: CD003869. doi: 10.1002/14651858.CD003869.pub2.
4. Quartz (Lu24). Quality of life after radiotherapy and steroids. http://www.ctu.mrc.ac.uk/studies/LU24.asp [accessed 18 March 09].
5. Khanduri, S., Gerrard, G., Barton, R., Mulvenna, P., Lee, SM Clinical trials assessing the optimal management of brain metastases - the state of play. Clin Oncol 2006; 18: 744-746.
6. Barton, R. Inoperable brain metastases from non-small cell lung cancer: what part does whole brain radiotherapy play in standard treatment? Thorax 2008; 63: 1-2.
7. Bezjak, A., Adam, J., Panzarella, T., Wilfred, L., Barton, R., Kirkbride, P., et al. Radiotherapy for brain metastases: Defining palliative response. Radiother Oncol 2001; 61: 71-76.
8. Murray, KJ, Scott, C., Greenberg, HM, Emami, B., Seider, M., Vora, NL, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: A report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys 1997; 39: 571-574.
9. Smith, J., Osborn, M. Interpretative phenomenological analysis. In: Breakwell, GM, (ed), Doing social psychology research, chap. 10, p. 230. Oxford: Wiley Blackwell; 2004.
10. Spencer, L., Ritchie, J., O'Connor, W. Analysis: Practices, principles and processes. In: Ritchie, J, Lewis, J, (eds), Qualitative research practice. London, Thousand Oaks, New Delhi: Sage Publications Limited; 2003. pp. 199 - 218.
11. Sze, J., Marisette, S., Williams, D., Nyhof-Young, J., Crooks, D., Husain, A., et al. Decision making in palliative radiation therapy: reframing hope in caregivers and patients with brain metastases. Support Care Cancer 2006; 14: 1055-1063.
12. Knops, KM, Srinivasan, M., Meyers, FJ Patient desires: A model for assessment of patient preferences for care of severe or terminal disease. Palliat Support Care 2005; 3: 289-299.
13. Hughes, T., Chumacher, M., Jacobs-Lawson, JM, Arnold, S. Confronting death: Perceptions of a good death in adults with lung cancer. Am J Hosp Palliat Care 2008; 25: 39-44.
14. Hirose, T., Horichi, N., Ohmori, T., Kusumoto, S., Sugiyama, T., Shirai, T., et al. Patient preferences in chemotherapy for advanced non-small cell lung cancer. Intern Med 2005; 44: 107-113.
15. Brundage, MD, Feldman-Stewart, D., Cosby, R., Gregg, R., Dixon, P., Youssef, Y., et al. Cancer patients'' attitudes toward treatment options for advanced non-small cell lung cancer: Implications for patient education and decision support. Patient Educ Couns 2001; 45: 149-157.
16. Brundage, MD, Davidson, JR, Mackillop, WJ Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol 1997; 15: 330-345.
17. Chow, E., Andersson, L., Wong, B., Vachon, M., Hruby, G., Franssen, E., et al. Patients with advanced cancer: A survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases. Clin Oncol (R Coll Radiol) 2001; 13: 204-208.
18. Audrey, S., Abel, J., Blazeby, JM, Falk, S., Campbell, R. What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: Qualitative study. BMJ 2008; 337: A752.
19. Kondziolka, D., Nivanjan, A., Flickinger, JC, Lunsford, LD Radiosurgery with or without whole brain radiotherapy for brain metastases: The patients' perspectives regarding complications. Am J Clin Oncol 2005; 28: 173-179.
20. Davidson, JR, Brundage, MD, Feldman-Stewart, D. Lung cancer treatment decisions: Patients' desires for participation and information. Psychooncology 1999; 8: 511-520.
21. Pease, NJ, Edwards, A., Moss, LJ Effectiveness of whole brain radiotherapy in the treatment of brain metastases: A systematic review. Palliat Med 2005; 19: 288-299.